Skip to content
Book Now

Educational only — not medical advice. This page explains the published mechanism of a neurological condition and of a prescription treatment for general education. Botulinum toxin (Botox, Dysport, Daxxify) is a prescription medicine, FDA-approved for cervical dystonia in adults; every treatment has side effects, and whether it fits you is a decision made with a physician. This is not a diagnosis, not a treatment plan, and not a substitute for evaluation by a qualified clinician.

Cervical Dystonia: An Order Without a Brake

A 93-second narrated mechanism animation on why your head won't stay where you put it, why a touch to the chin eases it, and what botulinum toxin does to the muscles that pull — with the full transcript and the peer-reviewed references behind every claim, so you can check what the science actually says.

Mechanism animation · about 93 seconds · narrated · 9:16 vertical. Educational only — not medical advice.

About the treatment in this video. Botulinum toxin is FDA-approved for cervical dystonia in adults, in the label's words to reduce the severity of abnormal head position and neck pain — for onabotulinumtoxinA (Botox), abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), rimabotulinumtoxinB (Myobloc) and daxibotulinumtoxinA (Daxxify).[12,19] The 2020 Cochrane review calls it the first-line therapy; a single treatment improved the standard dystonia score by about 8 points versus placebo at week 4, a real but partial change that wears off and is repeated in cycles.[4] Same molecule as the chronic migraine film and the jaw-clenching film, a different job: here the target is the over-driven neck muscle, and the use is on-label.

Transcript

What the video says, beat by beat

  1. Shot 1 · Hook · ~8s

    Your head won't stay put

    “Your head won't stay where you put it. It turns or tilts on its own, and a touch on your chin somehow helps.”[1,2,3]

  2. Shot 2 · Anatomy · ~9s

    It has a name

    “That isn't a stiff neck, and it isn't stress. It's cervical dystonia, and these neck muscles are only doing what they're told.”[1,4,5]

  3. Shot 3 · The network · ~14s

    The order has no brake

    “The fault is the order. The brain network that shapes movement has lost its brake, so the signal never fully switches off. A touch feeds it new information, and the pull eases.”[6,7,8,9,10]

  4. Shot 4 · The handshake, firing then locked · ~23s

    SNAP-25 cut, the muscle goes quiet

    “Every order ends in a handshake between nerve and muscle. Packets of messenger cross the gap, and the fiber tightens. Botulinum toxin, whether it's Botox, Dysport, or Daxxify, slips into that ending and cuts the docking protein, SNAP-25. The packets stay locked, and the muscle goes quiet.”[11,12,13,14,15]

  5. Shot 5 · The map · ~13s

    Only the muscles that pull

    “So the injections go only into the muscles that pull, guided by EMG and ultrasound, while the other side keeps working. The goal is less pull, less pain, a head closer to the middle.”[12,4,16]

  6. Shot 6 · What to expect · ~13s

    Usual versus rare — call your doctor

    “Usually, it's a sore or weak neck, some tiredness, or trouble swallowing for a few weeks. Rarely, weakness that spreads, or trouble breathing. If that happens, call your doctor.”[4,12]

  7. Shot 7 · Close · ~12s

    Approved for exactly this

    “It's approved for cervical dystonia, it's the first-line treatment, and it's repeated in cycles, with therapy in between. Educational only. See a specialist.”[12,4,17,18]

“An order without a brake” is the plain-language version of the neurophysiology: dystonia is defined as sustained or intermittent involuntary contractions that produce abnormal postures or movements,[1] and the measured fault is a loss of inhibition at spinal, brainstem and cortical levels across a network that includes the basal ganglia, the cerebellum and the sensorimotor cortex.[6,7,8] The film keeps every number off the soundtrack on purpose. The figures live here: a mean of 3.5 providers over 44 months before diagnosis,[5] a sensory trick in 89.6% of patients,[3] an 8.09-point improvement on the TWSTRS scale versus placebo after one treatment,[4] and difficulty swallowing in 11% of pooled trial participants and 19% in the Botox label's own trials.[4,12] “Guided by EMG and ultrasound” describes how the injection is placed; the Cochrane review found no variation in efficacy with EMG guidance, so this page makes no claim that guidance improves the result.[4] Shot 5 shows the principle — only the pulling muscles are treated, which muscles depends on the pattern — as points of light on a stylized rear view, not as an injection map. Who gets cervical dystonia, how common it is, and how often it remits on its own are answered below, with their sources.[2,20,21,22]

What the science says

References

According to PubMed: every journal reference below was verified against its live PubMed record on September 15, 2026 and re-checked on September 16, 2026; the prescribing-information reference is the current DailyMed label. Numeric findings from individual studies are attributed to those studies and are not promises of results. Three references carry industry ties and say so. The 2016 AAN guideline is listed as historical context — the AAN has retired it. No clinic-specific dosing appears on this page.

  1. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863-873.

    Covers: the consensus definition: dystonia is a movement disorder of sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures or both; the movements are patterned and twisting, may be tremulous, and are often set off or worsened by voluntary action — “your head won't stay where you put it”, “it turns or tilts”, and the beat that the muscles are only doing what they're told

    PubMed · PMID 23649720 · DOI · 10.1002/mds.25475

  2. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991;41(7):1088-1091.

    Covers: 300 patients — 61% women, mean age 49.7; rotation (torticollis) in 82%, tilt in 42%, backward pull in 29%, forward pull in 25%, combinations in 66%; local pain in 68%; tremor in 71%, most of it head-neck tremor — the “turns or tilts” and “shakes” of the hook, and why pain is part of the picture

    PubMed · PMID 2067638 · DOI · 10.1212/wnl.41.7.1088

  3. Patel N, Hanfelt J, Marsh L, Jankovic J; members of the Dystonia Coalition. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014;85(8):882-884.

    Covers: 154 people at 10 sites — 138 (89.6%) used an alleviating manoeuvre, 43.4% of them with partial and 39.8% with marked improvement in posture; a light touch, usually to the lower face or neck, in more than 90%; having a trick did not track with severity — “a touch on your chin somehow helps”, and why the film says most people with it have one, never everyone

    PubMed · PMID 24828895 · DOI · 10.1136/jnnp-2013-307316

  4. Rodrigues FB, Duarte GS, Marques RE, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2020;11(11):CD003633.

    Covers: the current evidence anchor — cervical dystonia is the most common focal dystonia and botulinum toxin type A is considered the first-line therapy; 9 randomized trials, 1,144 participants: a single session improved the TWSTRS total score by 8.09 points versus placebo at week 4 (about 18% from baseline) and the pain subscore by 2.11, moderate-certainty evidence; most common treatment-related effects neck weakness 14%, dysphagia 11%, diffuse weakness or tiredness 8%; no difference between formulations and no variation in efficacy with EMG-guided injection — the “first-line”, “repeated in cycles” and “what to expect” beats. The page never claims guidance improves outcomes

    PubMed · PMID 33180963 · DOI · 10.1002/14651858.CD003633.pub4

  5. Tiderington E, Goodman EM, Rosen AR, Hapner ER, Johns MM 3rd, Evatt ML, Freeman A, Factor S, Jinnah HA. How long does it take to diagnose cervical dystonia?. J Neurol Sci. 2013;335(1-2):72-74.

    Covers: 146 consecutive patients, 108 analyzed — a mean of 3.5 providers over a mean of 44 months from symptom onset to diagnosis, in a condition the authors call readily identifiable by a simple history and examination — the “it has a name” beat, and the years of stiff-neck treatment the film speaks to

    PubMed · PMID 24034410 · DOI · 10.1016/j.jns.2013.08.028

  6. Hallett M. Neurophysiology of dystonia: The role of inhibition. Neurobiol Dis. 2011;42(2):177-184.

    Covers: loss of inhibitory function demonstrated at spinal, brainstem and cortical levels; failure of surround inhibition appears to lead directly to overflow and unwanted muscle spasms; mild sensory abnormalities and deficits in sensorimotor integration — “has lost its brake, so the signal never fully switches off”

    PubMed · PMID 20817092 · DOI · 10.1016/j.nbd.2010.08.025

  7. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord. 2013;28(7):958-967.

    Covers: three abnormalities — loss of inhibition, sensory dysfunction and altered synaptic plasticity — producing abnormal sensorimotor integration and the consolidation of abnormal motor programs — the “order” the film describes

    PubMed · PMID 23893452 · DOI · 10.1002/mds.25532

  8. Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum?. Neuroscience. 2014;260:23-35.

    Covers: the emerging view that dystonia is a network disorder involving several brain regions, with the cerebellum implicated alongside the basal ganglia — why the film says “a brain network” and never “a basal ganglia disease”

    PubMed · PMID 24333801 · DOI · 10.1016/j.neuroscience.2013.11.062

  9. Ramos VF, Karp BI, Hallett M. Tricks in dystonia: ordering the complexity. J Neurol Neurosurg Psychiatry. 2014;85(9):987-993.

    Covers: a classification of sensory, motor, imaginary, forcible and reverse tricks; neurophysiologic evidence suggesting that sensory tricks work by decreasing abnormal facilitation in the dystonic brain — “a touch feeds it new information, and the pull eases”, stated as what the evidence suggests

    PubMed · PMID 24487380 · DOI · 10.1136/jnnp-2013-306971

  10. Naumann M, Magyar-Lehmann S, Reiners K, Erbguth F, Leenders KL. Sensory tricks in cervical dystonia: perceptual dysbalance of parietal cortex modulates frontal motor programming. Ann Neurol. 2000;47(3):322-328.

    Covers: H2(15)O PET in 7 patients — during the trick, activation rose in the superior and inferior parietal lobule and occipital cortex and fell in the supplementary motor area and primary sensorimotor cortex — the shot-3 visual, in which the thread from the chin rises to the upper-back part of the brain and the motor command thins

    PubMed · PMID 10716251

  11. Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014;12(8):535-549.

    Covers: neuronal binding, internalization and cleavage of the SNARE proteins that dock and release neurotransmitter packets; type A toxin cleaves SNAP-25 — “slips into that ending and cuts the docking protein, SNAP-25”. The same anchor as the migraine and jaw films

    PubMed · PMID 24975322 · DOI · 10.1038/nrmicro3295

  12. BOTOX® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use — US Prescribing Information. Allergan, Inc. (an AbbVie company). DailyMed, U.S. National Library of Medicine; label published August 3, 2026.

    Covers: §1.5: indicated for the treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain; §12.1: binds acceptor sites on motor nerve terminals, enters them, inhibits acetylcholine release by cleaving SNAP-25, producing partial chemical denervation and a localized reduction in muscle activity; §14.7: the injected muscles in the cervical dystonia trial were chosen on an individual patient basis; §6.1: most frequent adverse reactions in cervical dystonia dysphagia 19%, upper respiratory infection 12%, neck pain 11%, headache 11%, most dysphagia mild or moderate; boxed warning on distant spread of toxin effect — swallowing and breathing difficulties, which can be life-threatening, and generalized weakness, hours to weeks after injection — the “goes quiet”, “only the muscles that pull”, “what to expect” and “approved for exactly this” beats

    DailyMed · full prescribing information

  13. Rosales RL, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve. 1996;19(4):488-496.

    Covers: an animal (rat) study — both extrafusal and intrafusal (muscle-spindle) fibers are cholinergically innervated and both were progressively affected, so the toxin's effect in dystonia may also involve modified spindle afferent discharge — why quieting the muscle may also quiet the feedback into the network (stated on this page, not in the film)

    PubMed · PMID 8622728 · DOI · 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8

  14. Trompetto C, Currà A, Buccolieri A, Suppa A, Abbruzzese G, Berardelli A. Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex. Mov Disord. 2006;21(6):777-782.

    Covers: 10 patients with writer's cramp (focal hand dystonia, not cervical dystonia) — the toxin reduced the tonic vibration reflex more than it reduced maximal strength, and the reflex stayed depressed at 7 months when strength had recovered; the authors suggest the action on spindle fibers alters sensorimotor integration and contributes to the benefit

    PubMed · PMID 16463352 · DOI · 10.1002/mds.20801

  15. Drużdż A, Leśniewska-Furs E, Dudzic M, Sowińska A, Jurga S, Jost WH. Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin Therapy. Toxins (Basel). 2025;18(1):21.

    Covers: 21 patients, no control group — after treatment, F-wave latency lengthened, F-wave amplitude fell and the cutaneous silent period lengthened, which the authors read as reduced spinal motoneuron excitability and stronger spinal inhibition beyond local chemodenervation; small and uncontrolled, so this page treats it as a lead, not a proof

    PubMed · PMID 41591167 · DOI · 10.3390/toxins18010021

  16. Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, Schwartz M, Brin MF. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol. 2014;261(7):1309-1319.

    Covers: 1,037 registry patients — the moderate-to-severe pain group had higher TWSTRS severity (17.7 versus 16.2) and disability (12.7 versus 7.5), and pain tracked disability more closely than posture did — “less pull, less pain”: pain is part of the indication, not a side issue. Industry-sponsored registry (Allergan)

    PubMed · PMID 24752807 · DOI · 10.1007/s00415-014-7343-6

  17. Tassorelli C, Mancini F, Balloni L, Pacchetti C, Sandrini G, Nappi G, Martignoni E. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord. 2006;21(12):2240-2243.

    Covers: 40 patients in a controlled cross-over design — toxin plus a specific physical-therapy program gave a longer benefit (118.8 versus 99.1 days) and a lower dose at re-injection, with larger reductions in disability and pain — “repeated in cycles, with therapy in between”

    PubMed · PMID 17029278 · DOI · 10.1002/mds.21145

  18. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818-1826.

    Covers: historical context only — the 2016 American Academy of Neurology guideline rated abobotulinumtoxinA and rimabotulinumtoxinB established effective (Level A) and onabotulinumtoxinA and incobotulinumtoxinA probably effective (Level B) for cervical dystonia. The AAN has since retired this guideline (the PubMed record carries [RETIRED] in its title), so this page leans on the 2020 Cochrane review for the first-line statement

    PubMed · PMID 27164716 · DOI · 10.1212/WNL.0000000000002560

  19. Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, Vitarella D, Rubio RG, Gross TM; ASPEN-1 Study Group. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology. 2024;102(4):e208091.

    Covers: 301 randomized — TWSTRS total change versus placebo −8.5 points at the 125-unit dose and −6.6 at 250 units; median duration of effect 24.0 and 20.3 weeks; dysphagia 1.6% and 3.8% versus 0% on placebo; Class I evidence. Published trial figures, not clinic dosing. Industry-funded (Revance)

    PubMed · PMID 38295339 · DOI · 10.1212/WNL.0000000000208091

  20. Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S; U.S. XEOMIN Cervical Dystonia Study Group. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci. 2011;308(1-2):103-109.

    Covers: 233 participants, 66% women, mean age 52.8, cervical dystonia for a mean of 51.9 months — TWSTRS total change at week 4 of −2.2 on placebo versus −9.9 and −10.9 on the two doses; most frequent effects dysphagia, neck pain and muscular weakness, generally mild — who gets it, and the consistency of the effect across type-A products. Industry-funded (Merz)

    PubMed · PMID 21764407 · DOI · 10.1016/j.jns.2011.05.041

  21. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012;27(14):1789-1796.

    Covers: 16 studies — service-based prevalence of primary dystonia 16.43 per 100,000, higher in population-based studies; the one study reporting it found a corrected incidence of cervical dystonia of 1.07 per 100,000 per year — how common it is

    PubMed · PMID 23114997 · DOI · 10.1002/mds.25244

  22. Jahanshahi M, Marion MH, Marsden CD. Natural history of adult-onset idiopathic torticollis. Arch Neurol. 1990;47(5):548-552.

    Covers: 72 patients followed a mean of 7.7 years — spontaneous remission in 15 (20.8%), sustained in 9 (12.5%) for a median of 3 years, 87% of remissions in the first 5 years, spread to other body sites in 32% — why the page says remission happens in a minority and is often temporary

    PubMed · PMID 2334302 · DOI · 10.1001/archneur.1990.00530050070014

Common questions about cervical dystonia and botulinum toxin

Yes. OnabotulinumtoxinA (Botox) is a prescription medicine whose label lists cervical dystonia in adults as an approved indication, in the label's words to reduce the severity of abnormal head position and neck pain. AbobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), rimabotulinumtoxinB (Myobloc) and daxibotulinumtoxinA (Daxxify) are also approved for it; Daxxify's approval rests on the ASPEN-1 trial published in 2024. All carry a boxed warning about the toxin's effect spreading beyond the injected muscles. This is different from the jaw-clenching use shown in another film on this site, which is off-label. This page is educational and cannot tell you whether any treatment is appropriate for you. Source: BOTOX US Prescribing Information; Comella 2024 (Neurology).

That is the sensory trick, and it is one of the signatures of cervical dystonia rather than a coincidence. In a study of 154 people at 10 centers, 138 (89.6%) used one; for more than 90% of them it was a light touch, usually to the lower face or neck, and it eased the posture partly in 43.4% and markedly in 39.8%. The touch does not work by force. The evidence suggests it works by feeding the movement network new sensory information that reduces its abnormal facilitation: in a PET study of 7 patients, the trick raised activity in the parietal cortex, which handles the sense of where the body is, and lowered activity in the motor-planning areas that issue the pull. Most people with cervical dystonia have a trick and few mention it, which is one reason the diagnosis is missed. Source: Patel 2014 (J Neurol Neurosurg Psychiatry); Ramos 2014 (J Neurol Neurosurg Psychiatry); Naumann 2000 (Ann Neurol).

Because they are following an order. Dystonia is defined as sustained or intermittent involuntary muscle contractions that produce abnormal, often repetitive movements or postures, and the fault is in the brain network that shapes movement, not in the muscles or the spine. Neurophysiology shows a loss of inhibition at spinal, brainstem and cortical levels, so the signal to the muscles never fully switches off and spills over into muscles that should be resting; sensory processing and the brain's ability to adjust its own wiring are abnormal too. The regions involved include the basal ganglia, the cerebellum and the sensorimotor cortex, which is why researchers now describe dystonia as a network disorder rather than a single-structure disease. The film compresses this into one image: an order with no brake. Source: Albanese 2013 (Mov Disord); Hallett 2011 (Neurobiol Dis); Quartarone and Hallett 2013 (Mov Disord); Prudente 2014 (Neuroscience).

Every order to a muscle ends at a neuromuscular junction, where the motor nerve ending releases packets of acetylcholine and the muscle fiber contracts. Botulinum toxin binds acceptor sites on that nerve ending, enters it, and cleaves SNAP-25, one of the docking proteins the packets need in order to be released. With the packets locked, the injected muscle receives less of the order and its activity falls; the label describes this as partial chemical denervation, localized to the injected muscle, which is why the muscles that are not pulling keep working. Two further effects are studied but not settled: in an animal study the toxin also affected the muscle spindles that send position feedback to the brain, and in a small uncontrolled study of cervical dystonia patients, spinal reflex measures shifted after treatment in a way the authors read as stronger spinal inhibition. This page reports those as leads, not as proven mechanisms. Source: Rossetto 2014 (Nat Rev Microbiol); BOTOX US Prescribing Information; Rosales 1996 (Muscle Nerve); Trompetto 2006 (Mov Disord); Drużdż 2025 (Toxins).

The 2020 Cochrane review pooled 9 randomized trials with 1,144 participants. A single treatment improved the TWSTRS total score, the standard cervical dystonia scale, by 8.09 points versus placebo at week 4, about 18% from baseline, and improved the pain subscore by 2.11 points, with moderate-certainty evidence. The review found no efficacy difference between the type-A products and no variation in efficacy with EMG-guided injection; guidance is the method used to place the injection, not a promise of a better result. The effect of one session wears off, so treatment is repeated in cycles. In the ASPEN-1 trial the median duration of effect of daxibotulinumtoxinA was 24 weeks at the 125-unit dose, a published trial figure rather than a clinic protocol. In a randomized cross-over study, adding a specific physical-therapy program lengthened the benefit of each cycle from about 99 to about 119 days and lowered the dose needed at re-injection. Source: Rodrigues 2020 (Cochrane); Comella 2024 (Neurology); Tassorelli 2006 (Mov Disord).

The common ones are local and temporary. In the Cochrane pooled analysis the most frequent treatment-related effects were neck weakness (14%), difficulty swallowing (11%) and diffuse weakness or tiredness (8%). In the Botox cervical dystonia trials the label reports difficulty swallowing in 19%, upper respiratory infection in 12%, neck pain in 11% and headache in 11%, with most swallowing difficulty mild or moderate. The rare, serious problem is the one in the boxed warning: the toxin's effect can spread beyond the injected muscles, hours to weeks after treatment, producing weakness that spreads, or trouble swallowing or breathing, which can be life-threatening. If that happens, call your doctor or seek urgent care. Source: Rodrigues 2020 (Cochrane); BOTOX US Prescribing Information.

It is the most common focal dystonia in adults, with a service-based prevalence of primary dystonia of about 16 per 100,000 in a meta-analysis and higher figures in population-based studies. In a series of 300 patients, 61% were women and the mean age was 49.7; in a later trial population, 66% were women with a mean age of 52.8. Most patients have pain in the pulling muscles and about seven in ten have a head tremor. It is often missed: one U.S. registry found a mean of 3.5 providers over 44 months before diagnosis. Spontaneous remission happens in a minority and is often temporary: in 72 patients followed for a mean of 7.7 years, 20.8% remitted at some point and 12.5% stayed in remission for a median of 3 years, with most remissions in the first 5 years. Source: Steeves 2012 (Mov Disord); Jankovic 1991 (Neurology); Comella 2011 (J Neurol Sci); Tiderington 2013 (J Neurol Sci); Jahanshahi 1990 (Arch Neurol).

If your head pulls, tilts, or shakes: what it usually is, and what we do about it

The pattern is diagnosed in the exam room, by watching the head at rest and against the pull and by asking about the touch that helps. Start with the cervical dystonia condition guide, and if you have only just noticed the pull, the early-symptoms guide.

The head turns, tilts, or pulls on its own, a light touch to the chin or cheek eases it, and the neck aches on the side that is pulling

Usually: Cervical dystonia

At Modal Pain: EMG and ultrasound-guided botulinum toxin (Botox, Dysport, or Daxxify) into the specific overactive muscles, repeated in cycles, with physical therapy between them

The head shakes side to side or nods, worse when you try to hold it straight, and there is a pull underneath the shake

Usually: Dystonic head tremor (a form of cervical dystonia)

At Modal Pain: The same muscle-mapped botulinum toxin injections — the tremor usually settles with the pull

Neck pain and spasm on one side, but the head stays straight, moves normally, and nothing eases it except rest

Usually: Cervical myofascial or facet-driven neck pain — not dystonia

At Modal Pain: Trigger point injections, or a medial branch block and radiofrequency ablation when the facet joints are the source

Botulinum toxin for cervical dystonia is an FDA-approved indication for Botox, Dysport, and Daxxify, and most commercial plans cover it with prior authorization, which our office handles. We do not participate with Medicare or Medicaid. Self-pay pricing is published, with no surprise fees. Insurance details · Self-pay pricing

Verify my insurance Book an evaluation (646) 290-6660

369 Lexington Ave, Floor 25, New York, NY 10017 · same-week appointments are routinely available · in-suite ultrasound and fluoroscopy.

Go deeper on this site

More in this series

Other mechanism animations

Does your head drift, and does a touch bring it back?

Cervical dystonia is diagnosed by examination, usually years after the first symptom, and it is treated by injecting only the muscles that pull. Dr. Movshis examines the pattern at every visit and performs EMG and ultrasound-guided botulinum toxin injections in-office in Midtown Manhattan. Botox, Dysport and Daxxify are prescription treatments, FDA-approved for cervical dystonia in adults; every treatment has side effects, and whether it is right for you is a decision made with a physician.

Book an Appointment (646) 290-6660 Free Insurance Check
5.0 82 Google Reviews Dual ABA Board-Certified Anesthesiology & Pain Medicine 369 Lexington Ave, Floor 25 Midtown Manhattan, NYC 10017

Educational only — not medical advice. Nothing on this page is medical advice, a diagnosis, or a guarantee of any outcome. Botulinum toxin (Botox, Dysport, Daxxify) is a prescription medicine; it carries a boxed warning for distant spread of toxin effect — trouble swallowing or breathing, or weakness that spreads, hours to weeks after an injection, needs a call to your doctor or urgent care.[12] A neck that locks suddenly with fever, a severe headache or a stiff neck you cannot flex needs emergency care. A sudden twisting of the neck, eyes or jaw within hours or days of starting a nausea medicine or an antipsychotic is an acute dystonic reaction and needs same-day treatment. A new head posture with arm weakness, numbness, or trouble with balance or speech needs same-day evaluation.

★★★★★
5 out of 5 based on 82 reviews
View all reviews on Google →

"From the day one, it was very clear I was in the hands of someone who truly cares. Dr. Movshis diagnosed my lumbar disc herniation with nerve compression to the details way…"

★★★★★
Dpak N3 months ago

"I’m so grateful to Dr. Alex for helping me recover from my hip pain. He was always professional, knowledgeable, and attentive, and took the time to listen to my concerns and…"

★★★★★
Yuka Mitoa month ago

"Dr. Alex is amazing, the kind of doctor you wish for in every way: punctual, professional, caring, thorough, knowledgeable. He helped me immensely with severe tennis elbow and I…"

Modal Pain Management NYC
369 Lexington Ave, Floor 25
View on Google Maps →